The USA300 strain of Staphylococcus aureus bacteria, colorized in gold, shown outside a white blood cell.
Bethesda, MD (Scicasts) - Scientists from the National Institutes of Health and University of Chicago have reported finding a promising treatment method that in laboratory mice reduces the severity of skin and soft-tissue damage caused by USA300, the leading cause of community-associated Staphylococcus aureus infections in the United States. According to the report, by neutralizing a key toxin associated with the bacteria, they found they could greatly reduce the damaging effects of the infection on skin and soft tissue. Community strains of S. aureus cause infection in otherwise healthy people and are considered extremely virulent, as opposed to hospital strains that infect people who already are weakened by illness or surgery.












